What is an intrasubstance tear of the Achilles tendon?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What is an Intrasubstance Tear of the Achilles Tendon?

An intrasubstance tear (also called an intratendinous tear or ITT) is a partial-thickness tear located centrally within the Achilles tendon substance that extends toward but does not penetrate through the tendon's outer surface, presenting as a distinct pathology separate from complete rupture or typical tendinopathy. 1

Clinical Definition and Characteristics

An intrasubstance tear is defined by specific imaging and clinical criteria that distinguish it from other Achilles pathologies:

  • Imaging appearance: On ultrasound, ITTs appear as a clearly visualized echopoor (dark) area situated centrally within the tendon that extends to, but not through, the tendon periphery 1
  • Clinical presentation: Patients have localized pain on palpation at the tear site but lack clinical findings consistent with complete Achilles rupture 1
  • Functional impact: Unlike complete ruptures, patients typically retain the ability to train but cannot reach maximal loading capacity 1

Epidemiology and Risk Factors

Intrasubstance tears represent a relatively uncommon but clinically significant entity:

  • Prevalence: ITTs account for approximately 5% of all patients presenting with Achilles pain (achillodynia) in specialist centers 1
  • Age distribution: Patients with ITTs are significantly younger (average 36.3 years) compared to those with mid-tendon tendinopathy (difference of 8.48 years; p<0.01) 1
  • Athletic population: Elite athletes are disproportionately affected, with 86.2% of ITT cases occurring in elite sportspeople versus 13.8% in the mid-tendon tendinopathy group (p<0.01) 1
  • Gender: Males are more commonly affected, with a male-to-female ratio of approximately 3.6:1 (29 males to 8 females) 1
  • Concurrent pathology: 92% of patients with ITTs have coexisting Achilles tendinopathy 1

Clinical Presentation

The typical presentation pattern helps distinguish ITTs from other Achilles pathologies:

  • Onset: Sudden onset of localized pain, often during high-impact activities 1
  • Pain pattern: Localized tenderness at the specific site of the intrasubstance defect 2, 1
  • Functional limitation: Ability to perform activities but inability to reach peak performance or maximal loading 1
  • Duration: May become chronic if not properly diagnosed, with some cases presenting after one year of persistent symptoms 2

Diagnostic Approach

Ultrasound is the primary imaging modality for identifying intrasubstance tears, showing the characteristic central echopoor defect that does not extend through the tendon surface. 1

Key diagnostic features to actively search for:

  • Central location: The tear is within the tendon substance, not at the surface 1
  • Incomplete extension: The defect extends toward but not through the tendon periphery 1
  • Point tenderness: Direct palpation over the visualized defect reproduces pain 1
  • Preserved continuity: Unlike complete ruptures, the tendon maintains structural continuity without gap formation 1

Clinical Significance

This pathology should be actively considered in specific clinical scenarios:

  • Elite male athletes with sudden-onset Achilles pain following high-impact activities are at highest risk 1
  • Younger patients (under 40 years) presenting with localized Achilles pain should be evaluated for ITT rather than assuming typical tendinopathy 1
  • Refractory cases: When conservative treatment for presumed tendinopathy fails, ITT should be reconsidered as the underlying diagnosis 2

Treatment Considerations

While comprehensive treatment guidelines for ITTs specifically are lacking, emerging evidence suggests:

  • Conservative management: Initial treatment typically involves activity modification and physical therapy, though response may be limited 2
  • Regenerative options: Microfragmented adipose tissue injection has shown promise in case reports, with documented healing and return to activity within 4 weeks and sustained improvement at 6 months 2
  • Surgical consideration: For chronic, refractory cases, surgical intervention may be warranted, though specific protocols for ITTs require further research 2, 1

Important Clinical Pitfalls

The primary pitfall is misdiagnosing an intrasubstance tear as simple tendinopathy, leading to prolonged ineffective conservative treatment. 1

  • Active search required: ITTs will be missed unless specifically looked for on imaging, particularly in high-risk populations 1
  • Distinguish from complete rupture: Unlike complete ruptures, ITTs maintain tendon continuity and patients retain some functional capacity 1
  • Consider in treatment failures: When standard tendinopathy treatment fails in younger, athletic patients, reassess for ITT 2, 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.